Clinical Trial

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

Study acronym: Phoenix CIP347
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the clinical performance of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in adult patients with Type 1 diabetes mellitus that cannot be controlled with subcutaneous insulin therapy (including external pump), and presenting with frequent, otherwise unexplained severe hyper- and/or hypoglycemia.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-07-10
notable Trial sites expanded: 6 -> 11 locations 2026-07-10
notable Sponsor changed: Medtronic Diabetes -> Medtronic MiniMed, Inc. 2026-04-19
Trial Details
NCT Number NCT06739811
Lead Sponsor Medtronic MiniMed, Inc.
Conditions Type I Diabetes
Enrollment 40 participants
Start Date 2025-03-21
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-06